Cannabinoid Receptors

5-Fluoro PB-22 N-(3-fluoropentyl) isomer is a structural isomer of 5-Fluoro PB-22, targeting the cannabinoid receptors. This compound exhibits significant biological activity related to the modulation of cannabinoid receptor signaling pathways. It is primarily utilized in research applications exploring cannabinoid pharmacology, drug interaction studies, and the development of therapeutic agents targeting the endocannabinoid system.

5-Fluoro PB-22 5-hydroxyisoquinoline isomer is a structural isomer of 5-Fluoro PB-22, targeting the cannabinoid receptors. This compound has been studied for its potential biological activities within the endocannabinoid system. It may be utilized in research related to neuropharmacology and the exploration of cannabinoid receptor modulation.

PB-22 6-Hydroxyquinoline isomer is a structural isomer of the cannabinoid PB-22, which primarily acts on the cannabinoid receptors. This compound may exhibit similar biological activities related to modulation of the endocannabinoid system, potentially influencing pain, inflammation, and mood regulation. It is suitable for research applications in pharmacology, toxicology, and cannabinoid receptor studies.

PB-22 7-Hydroxyquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound targets cannabinoid receptors and exhibits activity that may influence the endocannabinoid system. PB-22 7-Hydroxyquinoline isomer is primarily utilized in cannabinoid research to explore its pharmacological properties and potential therapeutic applications.

PB-22 8-Hydroxyisoquinoline isomer is a structural isomer of the synthetic cannabinoid PB-22. This compound acts primarily on cannabinoid receptors, modulating various signaling pathways. Its unique structure may offer insights into cannabinoid research and the development of novel therapeutic agents targeting the endocannabinoid system. PB-22 8-Hydroxyisoquinoline isomer is suitable for biochemical assays and pharmacological studies exploring cannabinoid receptor interactions.

PB-22 5-Hydroxyquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound exhibits biological activity related to cannabinoid receptor modulation, making it relevant for pharmacological studies in endocannabinoid signaling pathways. Research applications include investigating the effects of synthetic cannabinoids on neural activity and their potential therapeutic uses in pain management and other neuropsychiatric conditions.

PB-22 6-Hydroxyisoquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound exhibits cannabinoid receptor activity, thereby influencing endocannabinoid signaling pathways. It is primarily utilized in research settings to study the pharmacological effects of cannabinoid compounds and their potential therapeutic applications.

5-Fluoro PB-22 N-(4-fluoropentyl) isomer is a structural isomer of 5-Fluoro PB-22 that acts as a potent cannabinoid receptor agonist. This compound exhibits biological activities that may modulate cannabinoid signaling pathways, making it relevant for research in neuropharmacology and cannabinoid receptor biology. Its unique profile allows for investigations into the effects of synthetic cannabinoids on physiological and psychological processes.

PB-22 5-Hydroxyisoquinoline isomer is a structural isomer of the cannabinoid PB-22, targeting cannabinoid receptors in the central nervous system. This compound exhibits potential neuropharmacological activity, making it suitable for research into cannabinoids and their effects on various biological processes. Its unique structure allows for the exploration of the functional relationships between different isomers and their associated biological activity in preclinical studies.

5-Fluoro PB-22 6-hydroxyquinoline isomer is a structural isomer of 5-Fluoro PB-22, targeting cannabinoid receptors in the endocannabinoid system. This compound is utilized in research focused on cannabinoid receptor modulation and the investigation of its pharmacological effects. Its unique structure allows for the exploration of potential therapeutic applications and the study of receptor binding dynamics.

5-Fluoro PB-22 7-hydroxyisoquinoline isomer is a structural isomer of 5-Fluoro PB-22, primarily known for its activity at cannabinoid receptors. This compound exhibits potential in studying the effects of structural variations on cannabinoid receptor function and related signaling pathways. It is applicable in research focused on pharmacology, neuroscience, and the characterization of synthetic cannabinoids.

PB-22 7-Hydroxyisoquinoline isomer is a structural isomer of the cannabinoid PB-22. This compound exhibits potential biological activity by interacting with cannabinoid receptors, which play a crucial role in various physiological processes. Research applications include studies on cannabinoid receptor signaling and exploration of therapeutic effects in neurological and inflammatory disorders.

β-Caryophyllene is a potent agonist of the cannabinoid receptor type 2 (CB2). This compound is known for its anti-inflammatory and analgesic properties, making it a valuable tool in research focused on pain management and the endocannabinoid system. Additionally, β-Caryophyllene can be used to explore therapeutic applications in various disease models, including neurodegeneration and immune response studies.

Olivetol is a naturally occurring phenol that functions as a competitive inhibitor of cytochrome P450 enzymes, specifically CYP2C19 and CYP2D6, with IC50 values of 15.3 μM and 7.21 μM, respectively. Additionally, olivetol has demonstrated inhibitory activity against cannabinoid receptors CB1 and CB2. This compound is useful in research related to drug metabolism, pharmacokinetics, and the modulation of cannabinoid signaling pathways.

Anandamide-d4 is a deuterium-labeled derivative of Anandamide, which serves as a stable isotope standard for research applications. This compound is primarily utilized in studies investigating the endocannabinoid system and its physiological effects, enabling precise quantification in metabolic and pharmacokinetic analyses. It aids researchers in elucidating cannabinoid receptor interactions and the role of endocannabinoids in various biological processes.

Arachidoyl ethanolamide is an ester derivative of arachidonic acid that functions primarily as a bioactive lipid mediator. It is known to modulate various physiological processes by interacting with cannabinoid receptors and has potential implications in pain modulation and inflammation. This compound is utilized in research to investigate endocannabinoid signaling pathways and their roles in various biological systems.

2-[4-(Aminomethyl)triazol-1-yl]ethanamine is a specialized PROTAC linker that serves as a crucial component in targeted protein degradation strategies. This compound facilitates the synthesis of PROTAC CB1R Degrader-1, enabling the effective modulation of cannabinoid receptor 1 (CB1R) levels. Its application in research supports investigations into protein homeostasis and therapeutic approaches for various diseases.

Rimonabant carboxylic acid is a ligand used for the targeted protein degradation (PROTAC) approach by engaging with the target protein. This compound plays a crucial role in synthesizing PROTAC CB1R Degrader-1, facilitating the study of cannabinoid receptor biology and influencing metabolic processes. It serves as a valuable tool for researchers investigating innovative therapeutic strategies for conditions related to the endocannabinoid system.

C18:1 Anandamide is an endocannabinoid lipid that primarily targets cannabinoid receptors, particularly CB1 and CB2. It exhibits various biological activities, including modulation of pain, appetite, and mood. C18:1 Anandamide is widely utilized in research focused on the endocannabinoid system, neurobiology, and the therapeutic potential of cannabinoids in a range of physiological processes and disorders.

N-20:4 L-Serine MeEster is a lipid-derived compound that functions as a structural analog of anandamide. It exhibits significant biological activity in modulating cannabinoid receptor signaling pathways, making it a valuable reagent for studying lipid-mediated cellular processes. This compound is useful in various research applications, including investigations of endocannabinoid system dynamics and lipid signaling in neurobiology.

C17:0 Anandamide phosphate sodium is a lipid derivative of anandamide, primarily targeting cannabinoid receptors. This compound possesses bioactive properties that may influence various physiological pathways, making it a valuable tool in studies related to endocannabinoid signaling, lipid metabolism, and neurobiology. Its applications include investigating the role of lipid mediators in inflammation, pain, and neurodegenerative diseases.

C20:4 Anandamide (AEA) is a bioactive lipid that acts as an endocannabinoid, primarily targeting cannabinoid receptors in the central nervous system. This compound is known for its involvement in pain modulation, appetite regulation, and neuroprotection. C20:4 AEA is commonly utilized in research to investigate the physiological effects of endocannabinoids and their potential therapeutic applications in various neurological and inflammatory conditions.

Oleoylsulfamide is a selective inhibitor of cannabinoid receptor 1 (CB1). This compound can be utilized as a biochemical assay reagent to investigate the role of CB1 in various physiological processes. It is particularly valuable in studies related to metabolic disorders, pain modulation, and neuroprotection.

C17:1 Anandamide is a synthetic derivative of anandamide, a significant endocannabinoid that interacts primarily with cannabinoid receptors. This compound demonstrates key biological activities, including modulation of pain perception, appetite, and mood regulation. C17:1 Anandamide is useful for studying the endocannabinoid system and its implications in various therapeutic areas, such as neurobiology and pain management. Its unique lipid structure enables investigations into lipid signaling pathways and their role in cellular processes.

N-Arachidonoyl-L-Serine sodium is a lipid compound that acts as an analog of anandamide, a well-known endocannabinoid. This reagent exhibits important biological activities, including the modulation of pain sensation, inflammation, and neuroprotection. It is utilized in research exploring cannabinoid receptor pathways and their therapeutic potential in various neurological and inflammatory disorders.

C18:2 Anandamide phosphate sodium is a phospholipid derivative of anandamide, acting primarily on cannabinoid receptors. This compound exhibits bioactive properties that influence lipid signaling pathways and modulate neuronal communication. It is applicable in research exploring endocannabinoid system dynamics, neuroprotection, and potential therapeutic avenues for neurological disorders.

NBD AA is a fluorescent analog of anandamide that selectively targets cannabinoid receptors. This compound plays a critical role in lipid signaling pathways and is utilized in studies examining endocannabinoid system functions. Its fluorescent properties make NBD AA an effective tool for visualizing lipid distribution and activity in live cell imaging and various biochemical assays.

GW-405833 is a selective agonist of the cannabinoid receptor 2 (CB2), with an EC50 value of 0.65 nM. It exhibits a strong affinity for CB2, while displaying significantly lower activity at CB1, with EC50 and Ki values of 16.1 μM and 4772 nM, respectively. In addition to its agonistic effects at CB2, GW-405833 acts as a non-competitive antagonist at CB1, mediating analgesic and anti-inflammatory effects. Furthermore, it inhibits forskolin-stimulated cAMP production and down-regulates HIF-1α, potentially alleviating acute liver failure through modulation of glycolysis. This compound is useful for research in pain management, inflammation, and liver pathology.